I first started tracking AXSM on Monday Jan 7th (Pre-market at approx. $5.00), and it has since Sky-Rocketed to a high of $17.05 today pre-market Tuesday March 26th representing 248% in Gains, locking in enormous profits.
Hello everyone! Today I have a short term chart analysis for AXSM. You can see the FULL video analysis by clicking the link below in my signature description!
I have new updated charts, and new video's every day. Please follow me on tradingview, and subscribe to me on youtube!
Leave any questions or comments below, and I will get back to you as soon as possible!
Warning: High risk pharmaceutical company. I was early in my last chart in January.
Chart looks more promising to me now. The company is developing non opioid treatments for joint pain, depression, and Alzheimer's disease. Pipeline (see ling below) is in clinical trials. If trials fail often get large drops in price and vice versa. With the opioid crisis IF these...
Cash: $41 Million (cash runway into the second quarter of 2019)
Phase 3 CREATE-1 trial of AXS-02 in CRPS, interim efficacy analysis (late December 2017 to early January 2018)
•Phase 3 COAST-1 trial of AXS-02 in knee OA associated with BMLs, interim analysis (late December 2017 to early January 2018)
•Phase 3 STRIDE-1 trial of AXS-05 in TRD, top-line data (1H...
Current share price is testing the upward trending lower resistance line. As the lower resistance line crosses the $5 inflection line we could expect major movement ahead of the Q42017/Q12018 FDA catalysts.